25 XP   0   0   10

Moberg Pharma AB (publ)
Buy, Hold or Sell?

Let's analyse Moberg Pharma AB (publ) together

PenkeI guess you are interested in Moberg Pharma AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Moberg Pharma AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Moberg Pharma AB (publ)

I send you an email if I find something interesting about Moberg Pharma AB (publ).

Quick analysis of Moberg Pharma AB (publ) (30 sec.)










What can you expect buying and holding a share of Moberg Pharma AB (publ)? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr21.84
Expected worth in 1 year
kr36.80
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
kr14.96
Return On Investment
55.1%

For what price can you sell your share?

Current Price per Share
kr27.16
Expected price per share
kr14.60 - kr40.90
How sure are you?
50%

1. Valuation of Moberg Pharma AB (publ) (5 min.)




Live pricePrice per Share (EOD)

kr27.16

Intrinsic Value Per Share

kr-72.93 - kr-29.84

Total Value Per Share

kr-51.09 - kr-7.99

2. Growth of Moberg Pharma AB (publ) (5 min.)




Is Moberg Pharma AB (publ) growing?

Current yearPrevious yearGrowGrow %
How rich?$55.6m$46.6m$5.3m10.3%

How much money is Moberg Pharma AB (publ) making?

Current yearPrevious yearGrowGrow %
Making money-$480.9k-$358.1k-$122.7k-25.5%
Net Profit Margin-3.8%-517.3%--

How much money comes from the company's main activities?

3. Financial Health of Moberg Pharma AB (publ) (5 min.)




What can you expect buying and holding a share of Moberg Pharma AB (publ)? (5 min.)

Welcome investor! Moberg Pharma AB (publ)'s management wants to use your money to grow the business. In return you get a share of Moberg Pharma AB (publ).

What can you expect buying and holding a share of Moberg Pharma AB (publ)?

First you should know what it really means to hold a share of Moberg Pharma AB (publ). And how you can make/lose money.

Speculation

The Price per Share of Moberg Pharma AB (publ) is kr27.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Moberg Pharma AB (publ).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Moberg Pharma AB (publ), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr21.84. Based on the TTM, the Book Value Change Per Share is kr3.74 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Moberg Pharma AB (publ).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.02-0.1%-0.010.0%0.000.0%0.090.3%0.050.2%
Usd Book Value Change Per Share-0.02-0.1%0.341.3%-0.09-0.3%0.000.0%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%0.341.3%-0.09-0.3%0.000.0%0.030.1%
Usd Price Per Share1.39-0.76-0.24-0.89-1.19-
Price to Earnings Ratio-16.49-2.44--5.53--5.47-2.00-
Price-to-Total Gains Ratio-70.46--35.82--1.03--9.37--25.85-
Price to Book Ratio0.70-0.40-0.35-0.84-0.99-
Price-to-Total Gains Ratio-70.46--35.82--1.03--9.37--25.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.476992
Number of shares403
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.340.00
Usd Total Gains Per Share0.340.00
Gains per Quarter (403 shares)137.451.10
Gains per Year (403 shares)549.794.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1055054004-6
201100109009-2
30164916400132
40219921900186
502749274002210
603299329002614
703849384003118
804398439003522
904948494004026
1005498549004430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%21.019.00.052.5%26.030.00.046.4%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%25.015.00.062.5%37.016.03.066.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.056.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%25.015.00.062.5%37.016.03.066.1%

Fundamentals of Moberg Pharma AB (publ)

About Moberg Pharma AB (publ)

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.

Fundamental data was last updated by Penke on 2024-04-10 08:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Moberg Pharma AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Moberg Pharma AB (publ) earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Moberg Pharma AB (publ):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-3.8%+3.8%
TTM-3.8%YOY-517.3%+513.5%
TTM-3.8%5Y82.9%-86.6%
5Y82.9%10Y44.7%+38.1%
1.1.2. Return on Assets

Shows how efficient Moberg Pharma AB (publ) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.0% Return on Assets means that Moberg Pharma AB (publ) generated kr-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Moberg Pharma AB (publ):

  • The MRQ is -1.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM-0.9%-0.1%
TTM-0.9%YOY-0.8%-0.1%
TTM-0.9%5Y1.1%-2.0%
5Y1.1%10Y1.0%+0.1%
1.1.3. Return on Equity

Shows how efficient Moberg Pharma AB (publ) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.1% Return on Equity means Moberg Pharma AB (publ) generated kr-0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Moberg Pharma AB (publ):

  • The MRQ is -1.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-0.9%-0.1%
TTM-0.9%YOY-0.8%-0.1%
TTM-0.9%5Y2.1%-3.0%
5Y2.1%10Y1.7%+0.4%

1.2. Operating Efficiency of Moberg Pharma AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Moberg Pharma AB (publ) is operating .

  • Measures how much profit Moberg Pharma AB (publ) makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Moberg Pharma AB (publ):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4.9%+4.9%
TTM-4.9%YOY-640.9%+636.1%
TTM-4.9%5Y37.4%-42.3%
5Y37.4%10Y25.5%+11.9%
1.2.2. Operating Ratio

Measures how efficient Moberg Pharma AB (publ) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Moberg Pharma AB (publ):

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.056-0.056
TTM0.056YOY74.669-74.613
TTM0.0565Y15.284-15.228
5Y15.28410Y8.100+7.184

1.3. Liquidity of Moberg Pharma AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Moberg Pharma AB (publ) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.38 means the company has kr3.38 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Moberg Pharma AB (publ):

  • The MRQ is 3.383. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.714. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.383TTM3.714-0.331
TTM3.714YOY8.148-4.434
TTM3.7145Y6.720-3.006
5Y6.72010Y5.067+1.653
1.3.2. Quick Ratio

Measures if Moberg Pharma AB (publ) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.04 means the company can pay off kr3.04 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Moberg Pharma AB (publ):

  • The MRQ is 3.037. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.893. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.037TTM3.893-0.856
TTM3.893YOY8.125-4.232
TTM3.8935Y6.645-2.752
5Y6.64510Y4.675+1.970

1.4. Solvency of Moberg Pharma AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Moberg Pharma AB (publ) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Moberg Pharma AB (publ) to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.04 means that Moberg Pharma AB (publ) assets are financed with 3.8% credit (debt) and the remaining percentage (100% - 3.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Moberg Pharma AB (publ):

  • The MRQ is 0.038. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.041. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.038TTM0.041-0.003
TTM0.041YOY0.035+0.006
TTM0.0415Y0.086-0.045
5Y0.08610Y0.240-0.153
1.4.2. Debt to Equity Ratio

Measures if Moberg Pharma AB (publ) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 3.9% means that company has kr0.04 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Moberg Pharma AB (publ):

  • The MRQ is 0.039. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.043. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.039TTM0.043-0.004
TTM0.043YOY0.036+0.007
TTM0.0435Y0.110-0.067
5Y0.11010Y0.444-0.334

2. Market Valuation of Moberg Pharma AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Moberg Pharma AB (publ) generates.

  • Above 15 is considered overpriced but always compare Moberg Pharma AB (publ) to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -16.49 means the investor is paying kr-16.49 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Moberg Pharma AB (publ):

  • The EOD is -29.458. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.486. Based on the earnings, the company is expensive. -2
  • The TTM is 2.444. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-29.458MRQ-16.486-12.972
MRQ-16.486TTM2.444-18.931
TTM2.444YOY-5.528+7.973
TTM2.4445Y-5.471+7.916
5Y-5.47110Y2.002-7.474
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Moberg Pharma AB (publ):

  • The EOD is -4.681. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.619. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.519. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.681MRQ-2.619-2.061
MRQ-2.619TTM-1.519-1.101
TTM-1.519YOY-2.201+0.682
TTM-1.5195Y-9.428+7.909
5Y-9.42810Y-7.556-1.872
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Moberg Pharma AB (publ) is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Moberg Pharma AB (publ):

  • The EOD is 1.243. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.696. Based on the equity, the company is cheap. +2
  • The TTM is 0.400. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.243MRQ0.696+0.548
MRQ0.696TTM0.400+0.296
TTM0.400YOY0.352+0.047
TTM0.4005Y0.836-0.436
5Y0.83610Y0.989-0.153
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Moberg Pharma AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2163.740-106%-0.952+341%0.030-822%0.366-159%
Book Value Per Share--21.84220.406+7%7.464+193%15.986+37%15.694+39%
Current Ratio--3.3833.714-9%8.148-58%6.720-50%5.067-33%
Debt To Asset Ratio--0.0380.041-8%0.035+9%0.086-56%0.240-84%
Debt To Equity Ratio--0.0390.043-8%0.036+9%0.110-64%0.444-91%
Dividend Per Share----0%-0%-0%-0%
Eps---0.230-0.147-36%-0.033-85%1.001-123%0.591-139%
Free Cash Flow Per Share---1.451-1.404-3%-0.335-77%-0.729-50%-1.049-28%
Free Cash Flow To Equity Per Share---1.464-0.581-60%0.076-2033%-1.176-20%-0.579-60%
Gross Profit Margin--1.0001.111-10%1.072-7%1.042-4%0.008+13035%
Intrinsic Value_10Y_max---29.836--------
Intrinsic Value_10Y_min---72.933--------
Intrinsic Value_1Y_max---2.733--------
Intrinsic Value_1Y_min---4.754--------
Intrinsic Value_3Y_max---8.408--------
Intrinsic Value_3Y_min---16.581--------
Intrinsic Value_5Y_max---14.318--------
Intrinsic Value_5Y_min---30.835--------
Market Cap759434340.000+44%425014800.000231521220.000+84%177434129.753+140%311066586.642+37%383198203.049+11%
Net Profit Margin----0.0380%-5.1730%0.829-100%0.447-100%
Operating Margin----0.0490%-6.4090%0.374-100%0.255-100%
Operating Ratio---0.056-100%74.669-100%15.284-100%8.100-100%
Pb Ratio1.243+44%0.6960.400+74%0.352+98%0.836-17%0.989-30%
Pe Ratio-29.458-79%-16.4862.444-774%-5.528-66%-5.471-67%2.002-923%
Price Per Share27.160+44%15.2008.280+84%2.644+475%9.788+55%13.036+17%
Price To Free Cash Flow Ratio-4.681-79%-2.619-1.519-42%-2.201-16%-9.428+260%-7.556+188%
Price To Total Gains Ratio-125.901-79%-70.460-35.819-49%-1.027-99%-9.370-87%-25.851-63%
Quick Ratio--3.0373.893-22%8.125-63%6.645-54%4.675-35%
Return On Assets---0.010-0.009-13%-0.008-26%0.011-192%0.010-204%
Return On Equity---0.011-0.009-13%-0.008-26%0.021-150%0.017-162%
Total Gains Per Share---0.2163.740-106%-0.952+341%0.030-822%0.366-159%
Usd Book Value--55698120.00052036918.800+7%46686214.800+19%49063493.280+14%44170091.160+26%
Usd Book Value Change Per Share---0.0200.341-106%-0.087+341%0.003-822%0.033-159%
Usd Book Value Per Share--1.9921.861+7%0.681+193%1.458+37%1.431+39%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.021-0.013-36%-0.003-85%0.091-123%0.054-139%
Usd Free Cash Flow---3699345.600-3580420.800-3%-1936039.200-48%-2147486.400-42%-2818643.160-24%
Usd Free Cash Flow Per Share---0.132-0.128-3%-0.031-77%-0.066-50%-0.096-28%
Usd Free Cash Flow To Equity Per Share---0.134-0.053-60%0.007-2033%-0.107-20%-0.053-60%
Usd Market Cap69260411.808+44%38761349.76021114735.264+84%16181992.633+140%28369272.702+37%34947676.118+11%
Usd Price Per Share2.477+44%1.3860.755+84%0.241+475%0.893+55%1.189+17%
Usd Profit---587784.000-480920.400-18%-358188.000-39%2485382.400-124%1474040.520-140%
Usd Revenue---2720746.800-100%4986177.600-100%2969631.600-100%5356536.240-100%
Usd Total Gains Per Share---0.0200.341-106%-0.087+341%0.003-822%0.033-159%
 EOD+5 -3MRQTTM+11 -21YOY+13 -195Y+11 -2310Y+12 -22

3.2. Fundamental Score

Let's check the fundamental score of Moberg Pharma AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-29.458
Price to Book Ratio (EOD)Between0-11.243
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.037
Current Ratio (MRQ)Greater than13.383
Debt to Asset Ratio (MRQ)Less than10.038
Debt to Equity Ratio (MRQ)Less than10.039
Return on Equity (MRQ)Greater than0.15-0.011
Return on Assets (MRQ)Greater than0.05-0.010
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Moberg Pharma AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.462
Ma 20Greater thanMa 5029.353
Ma 50Greater thanMa 10021.659
Ma 100Greater thanMa 20018.234
OpenGreater thanClose28.660
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets634,732
Total Liabilities24,007
Total Stockholder Equity610,725
 As reported
Total Liabilities 24,007
Total Stockholder Equity+ 610,725
Total Assets = 634,732

Assets

Total Assets634,732
Total Current Assets69,493
Long-term Assets565,239
Total Current Assets
Cash And Cash Equivalents 60,555
Net Receivables 1,823
Inventory 7,115
Total Current Assets  (as reported)69,493
Total Current Assets  (calculated)69,493
+/-0
Long-term Assets
Property Plant Equipment 4,942
Long-term Assets Other 532,220
Long-term Assets  (as reported)565,239
Long-term Assets  (calculated)537,162
+/- 28,077

Liabilities & Shareholders' Equity

Total Current Liabilities20,540
Long-term Liabilities3,467
Total Stockholder Equity610,725
Total Current Liabilities
Short-term Debt 1,270
Accounts payable 19,270
Total Current Liabilities  (as reported)20,540
Total Current Liabilities  (calculated)20,540
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,467
Long-term Liabilities  (calculated)0
+/- 3,467
Total Stockholder Equity
Common Stock27,961
Retained Earnings -338,533
Other Stockholders Equity 921,297
Total Stockholder Equity (as reported)610,725
Total Stockholder Equity (calculated)610,725
+/-0
Other
Cash and Short Term Investments 60,555
Common Stock Shares Outstanding 27,961
Liabilities and Stockholders Equity 634,732
Net Debt -55,818
Net Working Capital 48,953
Short Long Term Debt Total 4,737



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
> Total Assets 
0
0
0
12,383
18,324
77,528
83,782
92,453
132,545
135,852
139,315
280,762
265,941
265,108
275,808
271,609
281,025
358,634
349,174
359,720
405,176
416,873
404,829
397,454
686,736
726,095
835,926
1,232,176
1,226,652
1,211,921
1,194,648
1,223,257
1,219,316
1,265,678
1,247,026
1,251,614
1,864,852
1,209,972
1,232,509
134,932
369,282
129,942
364,060
479,704
463,209
456,488
453,512
450,889
451,762
555,677
549,807
564,423
551,296
549,719
644,179
634,732
634,732644,179549,719551,296564,423549,807555,677451,762450,889453,512456,488463,209479,704364,060129,942369,282134,9321,232,5091,209,9721,864,8521,251,6141,247,0261,265,6781,219,3161,223,2571,194,6481,211,9211,226,6521,232,176835,926726,095686,736397,454404,829416,873405,176359,720349,174358,634281,025271,609275,808265,108265,941280,762139,315135,852132,54592,45383,78277,52818,32412,383000
   > Total Current Assets 
0
0
0
11,699
17,438
76,422
82,985
91,698
102,059
105,799
110,916
101,255
85,753
78,742
94,995
59,219
68,993
136,429
115,848
117,445
148,409
138,475
126,126
119,113
410,054
473,398
226,686
220,873
218,146
205,765
226,580
233,404
217,857
262,648
220,372
211,950
1,602,464
932,128
945,698
38,956
59,381
43,021
33,890
165,938
144,250
127,050
114,185
104,655
82,646
163,305
143,871
127,760
87,242
54,926
105,146
69,493
69,493105,14654,92687,242127,760143,871163,30582,646104,655114,185127,050144,250165,93833,89043,02159,38138,956945,698932,1281,602,464211,950220,372262,648217,857233,404226,580205,765218,146220,873226,686473,398410,054119,113126,126138,475148,409117,445115,848136,42968,99359,21994,99578,74285,753101,255110,916105,799102,05991,69882,98576,42217,43811,699000
       Cash And Cash Equivalents 
0
0
0
2,761
10,835
64,895
57,350
74,052
64,084
79,470
85,656
53,423
36,275
32,497
59,899
26,438
19,227
75,596
61,318
61,763
52,655
34,613
42,718
44,656
228,790
196,145
111,141
85,404
74,045
36,559
120,759
118,737
102,481
122,173
120,747
110,085
1,596,943
919,134
893,213
32,164
51,616
31,021
30,006
19,286
133,611
124,195
111,407
101,955
73,440
160,055
142,453
124,850
84,540
51,951
101,504
60,555
60,555101,50451,95184,540124,850142,453160,05573,440101,955111,407124,195133,61119,28630,00631,02151,61632,164893,213919,1341,596,943110,085120,747122,173102,481118,737120,75936,55974,04585,404111,141196,145228,79044,65642,71834,61352,65561,76361,31875,59619,22726,43859,89932,49736,27553,42385,65679,47064,08474,05257,35064,89510,8352,761000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,425
200,388
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,404
0
0
0022,404000000000000000000000000000200,38894,425000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,934
89,859
127,075
80,006
77,291
88,315
120,134
77,002
73,089
5,521
12,994
52,485
6,217
7,765
6,747
3,884
2,135
10,639
2,855
2,778
2,000
9,206
3,250
1,418
383
2,702
2,975
3,642
1,823
1,8233,6422,9752,7023831,4183,2509,2062,0002,7782,85510,6392,1353,8846,7477,7656,21752,48512,9945,52173,08977,002120,13488,31577,29180,006127,07589,85979,934000000000000000000000000000
       Other Current Assets 
0
0
0
8,694
6,359
11,299
25,040
16,407
37,265
25,304
24,553
38,093
41,982
39,854
28,216
25,813
41,874
51,655
43,558
42,547
77,665
88,570
64,783
52,257
63,583
59,656
76,863
93,245
89,859
127,075
80,006
88,106
88,315
120,134
77,002
76,889
5,521
12,994
52,485
1
7,765
1
3,884
146,652
10,639
2,855
2,778
700
9,206
3,250
1,418
55
2,702
2,975
0
0
002,9752,702551,4183,2509,2067002,7782,85510,639146,6523,88417,765152,48512,9945,52176,88977,002120,13488,31588,10680,006127,07589,85993,24576,86359,65663,58352,25764,78388,57077,66542,54743,55851,65541,87425,81328,21639,85441,98238,09324,55325,30437,26516,40725,04011,2996,3598,694000
   > Long-term Assets 
0
0
0
683
886
1,106
796
755
30,486
30,053
28,399
179,507
180,188
186,366
180,813
212,390
212,032
222,205
233,326
242,275
256,767
278,398
278,703
278,341
276,682
252,697
609,240
1,011,303
1,008,506
1,006,156
968,068
989,853
1,001,459
1,003,030
1,026,654
1,039,664
262,388
277,844
286,811
0
309,901
0
330,170
313,766
318,959
329,438
339,327
346,234
369,116
392,372
405,936
436,663
464,054
494,793
539,033
565,239
565,239539,033494,793464,054436,663405,936392,372369,116346,234339,327329,438318,959313,766330,1700309,9010286,811277,844262,3881,039,6641,026,6541,003,0301,001,459989,853968,0681,006,1561,008,5061,011,303609,240252,697276,682278,341278,703278,398256,767242,275233,326222,205212,032212,390180,813186,366180,188179,50728,39930,05330,4867557961,106886683000
       Property Plant Equipment 
0
0
0
411
617
841
534
497
671
727
763
1,336
1,350
1,346
1,270
1,180
1,091
1,011
955
934
931
803
704
878
872
802
731
774
688
670
714
725
635
504
440
382
11,208
10,573
9,938
9,305
8,675
8,046
7,416
7,103
6,456
5,811
5,165
4,519
3,874
3,228
2,582
5,984
5,371
4,758
4,144
4,942
4,9424,1444,7585,3715,9842,5823,2283,8744,5195,1655,8116,4567,1037,4168,0468,6759,3059,93810,57311,2083824405046357257146706887747318028728787048039319349551,0111,0911,1801,2701,3461,3501,336763727671497534841617411000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
70,346
0
0
0
70,021
0
0
0
84,542
0
0
0
90,393
0
0
0
98,453
0
0
87,755
89,092
90,471
96,968
95,858
97,088
0
0
0
50,449
50,277
48,340
49,389
47,120
48,566
140,649
143,739
114,308
117,034
129,099
140,439
131,842
130,801
553,654
0
0
00553,654130,801131,842140,439129,099117,034114,308143,739140,64948,56647,12049,38948,34050,27750,44900097,08895,85896,96890,47189,09287,7550098,45300090,39300084,54200070,02100070,34600000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001111000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
85,625
0
0
0
111,799
0
0
0
131,820
0
0
0
170,800
0
0
0
901,914
996,753
991,874
869,208
890,781
750,260
897,514
923,267
937,130
242,253
255,654
273,835
45,528
296,295
44,315
315,495
295,733
300,412
310,706
320,406
327,042
349,562
368,311
381,492
408,104
435,015
465,363
507,910
0
0507,910465,363435,015408,104381,492368,311349,562327,042320,406310,706300,412295,733315,49544,315296,29545,528273,835255,654242,253937,130923,267897,514750,260890,781869,208991,874996,753901,914000170,800000131,820000111,79900085,62500000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,903
11,064
13,611
112,895
141,547
160,093
189,735
223,349
242,688
244,330
260,421
270,023
-1
294,376
306,274
315,904
306,663
312,503
323,627
334,162
341,715
365,242
389,144
403,354
430,679
0
490,035
0
0
00490,0350430,679403,354389,144365,242341,715334,162323,627312,503306,663315,904306,274294,376-1270,023260,421244,330242,688223,349189,735160,093141,547112,89513,61111,06471,903000000000000000000000000000
> Total Liabilities 
0
0
0
11,695
12,107
11,343
11,795
15,666
17,567
19,311
19,782
102,528
89,646
88,417
75,084
70,115
74,437
86,853
59,637
55,971
70,449
85,871
59,580
44,631
344,114
345,480
438,503
670,551
671,919
676,046
655,437
670,848
660,571
685,082
667,045
657,596
765,176
88,943
55,476
27,900
36,652
23,714
31,638
84,127
18,088
15,396
15,827
16,838
14,053
15,489
13,647
30,839
22,217
23,959
27,422
24,007
24,00727,42223,95922,21730,83913,64715,48914,05316,83815,82715,39618,08884,12731,63823,71436,65227,90055,47688,943765,176657,596667,045685,082660,571670,848655,437676,046671,919670,551438,503345,480344,11444,63159,58085,87170,44955,97159,63786,85374,43770,11575,08488,41789,646102,52819,78219,31117,56715,66611,79511,34312,10711,695000
   > Total Current Liabilities 
0
0
0
11,545
11,995
11,268
11,757
15,666
17,567
19,311
19,783
60,258
50,367
48,394
53,616
51,588
59,233
74,933
50,889
52,638
70,449
85,871
59,580
44,631
50,456
51,494
41,129
74,540
74,584
78,020
56,173
73,691
62,180
84,729
65,487
56,164
732,957
56,905
47,702
7,399
30,131
29,900
26,383
79,309
13,939
11,919
13,026
15,538
13,444
14,735
13,582
26,786
19,031
21,100
24,538
20,540
20,54024,53821,10019,03126,78613,58214,73513,44415,53813,02611,91913,93979,30926,38329,90030,1317,39947,70256,905732,95756,16465,48784,72962,18073,69156,17378,02074,58474,54041,12951,49450,45644,63159,58085,87170,44952,63850,88974,93359,23351,58853,61648,39450,36760,25819,78319,31117,56715,66611,75711,26811,99511,545000
       Short-term Debt 
0
0
0
0
11,995
11,268
11,757
0
17,567
19,311
19,783
12,222
50,367
48,394
53,616
13,333
59,233
74,933
50,889
13,333
70,449
85,871
59,580
3,333
50,456
51,494
41,129
589,040
74,584
78,020
56,173
591,788
62,180
84,729
65,487
0
732,957
56,905
47,702
0
30,131
0
26,383
2,642
13,939
11,919
2,581
2,696
2,709
2,723
1,773
2,117
1,742
1,636
979
1,270
1,2709791,6361,7422,1171,7732,7232,7092,6962,58111,91913,9392,64226,383030,131047,70256,905732,957065,48784,72962,180591,78856,17378,02074,584589,04041,12951,49450,4563,33359,58085,87170,44913,33350,88974,93359,23313,33353,61648,39450,36712,22219,78319,31117,567011,75711,26811,9950000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
589,040
589,790
590,456
591,122
591,788
592,454
593,120
0
0
730,692
54,539
45,233
0
0
0
5,837
0
11,283
9,250
0
0
0
0
0
0
0
0
0
0
00000000009,25011,28305,83700045,23354,539730,69200593,120592,454591,788591,122590,456589,790589,040000000000000000000000000000
       Accounts payable 
0
0
0
4,898
0
0
0
7,024
0
0
0
8,992
0
0
0
4,570
0
0
0
6,793
0
0
0
15,180
0
0
0
16,026
0
0
0
25,251
0
0
0
25,381
0
0
0
0
0
0
0
0
0
0
0
5,307
0
0
0
17,108
17,289
19,464
23,559
19,270
19,27023,55919,46417,28917,1080005,3070000000000025,38100025,25100016,02600015,1800006,7930004,5700008,9920007,0240004,898000
       Other Current Liabilities 
0
0
0
6,647
0
0
0
8,642
0
0
0
39,044
0
0
0
33,685
0
0
0
32,512
0
0
0
26,118
0
0
0
58,514
74,584
78,020
56,173
48,440
62,180
84,729
65,487
30,783
107,063
54,539
19,758
21,080
27,638
22,269
18,028
76,667
11,283
9,250
10,445
7,535
10,735
12,012
11,809
7,561
17,289
19,464
23,559
0
023,55919,46417,2897,56111,80912,01210,7357,53510,4459,25011,28376,66718,02822,26927,63821,08019,75854,539107,06330,78365,48784,72962,18048,44056,17378,02074,58458,51400026,11800032,51200033,68500039,0440008,6420006,647000
   > Long-term Liabilities 
0
0
0
150
113
75
38
0
0
0
-1
42,270
39,279
40,023
21,468
18,527
15,204
11,920
8,748
3,333
0
0
0
0
293,658
293,986
397,374
596,011
597,335
598,026
599,264
597,157
598,391
600,353
601,558
601,432
32,219
32,038
7,774
0
6,521
0
5,255
4,818
4,149
3,477
2,801
1,300
609
754
65
4,053
3,186
2,859
2,884
3,467
3,4672,8842,8593,1864,053657546091,3002,8013,4774,1494,8185,25506,52107,77432,03832,219601,432601,558600,353598,391597,157599,264598,026597,335596,011397,374293,986293,65800003,3338,74811,92015,20418,52721,46840,02339,27942,270-10003875113150000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,333
3,333
1,667
19,000
17,500
16,250
15,000
13,750
12,500
11,250
10,000
284,147
0
0
00284,14710,00011,25012,50013,75015,00016,25017,50019,0001,6673,3333,333000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,971
7,545
7,570
8,142
5,369
5,937
7,233
7,773
6,981
65
65
65
65
65
65
65
65
65
65
65
65
65
65
65
65
0
65
0
0
00650656565656565656565656565656565656,9817,7737,2335,9375,3698,1427,5707,5456,971000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,742
0
0
102,505
132,292
151,213
181,691
216,260
237,624
235,403
248,804
266,985
277,440
289,445
300,061
308,645
295,733
300,412
310,706
320,406
327,042
349,562
368,311
381,492
408,104
0
465,363
0
0
00465,3630408,104381,492368,311349,562327,042320,406310,706300,412295,733308,645300,061289,445277,440266,985248,804235,403237,624216,260181,691151,213132,292102,5050061,742000000000000000000000000000
> Total Stockholder Equity
0
0
0
688
6,217
66,185
71,987
76,787
114,979
116,541
119,533
178,234
176,295
176,691
200,724
201,494
206,588
271,781
289,537
303,749
334,727
331,002
345,249
352,823
342,622
380,615
397,423
561,625
554,733
535,875
539,211
552,409
558,745
580,596
579,981
594,018
1,099,676
1,121,029
1,177,033
107,032
332,630
106,228
332,422
387,870
445,121
441,092
437,685
434,051
437,709
540,188
536,160
533,584
529,079
525,760
616,757
610,725
610,725616,757525,760529,079533,584536,160540,188437,709434,051437,685441,092445,121387,870332,422106,228332,630107,0321,177,0331,121,0291,099,676594,018579,981580,596558,745552,409539,211535,875554,733561,625397,423380,615342,622352,823345,249331,002334,727303,749289,537271,781206,588201,494200,724176,691176,295178,234119,533116,541114,97976,78771,98766,1856,217688000
   Common Stock
0
0
0
611
0
0
0
908
0
0
0
1,081
1,081
1,081
1,189
1,189
1,189
1,396
1,396
1,396
1,396
1,396
1,400
1,422
1,422
1,429
0
1,741
1,741
1,744
1,744
1,744
558,745
1,744
1,744
1,744
1,099,676
1,818
1,867
1,704
1,867
1,870
1,931
2,087
4,405
4,405
4,405
4,405
4,522
9,827
9,827
9,827
9,827
9,827
27,961
27,961
27,96127,9619,8279,8279,8279,8279,8274,5224,4054,4054,4054,4052,0871,9311,8701,8671,7041,8671,8181,099,6761,7441,7441,744558,7451,7441,7441,7441,7411,74101,4291,4221,4221,4001,3961,3961,3961,3961,3961,1891,1891,1891,0811,0811,081000908000611000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,312
92,749
92,968
92,968
92,968
92,968
197,761
197,646
197,646
203,616
203,616
203,616
203,616
203,616
203,616
0
0
00203,616203,616203,616203,616203,616203,616197,646197,646197,76192,96892,96892,96892,96892,74992,312000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
114,858
0
0
0
197,044
0
0
0
262,505
263,317
267,968
295,819
297,015
298,039
358,956
372,319
386,795
406,861
397,680
403,146
410,307
405,754
415,745
0
586,122
57,716
45,119
562,113
565,745
42,135
587,233
584,439
587,516
0
0
0
0
857
-1
0
-1
731,174
730,469
730,972
731,376
739,359
840,438
840,660
841,197
842,175
842,255
920,884
921,297
921,297920,884842,255842,175841,197840,660840,438739,359731,376730,972730,469731,174-10-18570000587,516584,439587,23342,135565,745562,11345,11957,716586,1220415,745405,754410,307403,146397,680406,861386,795372,319358,956298,039297,015295,819267,968263,317262,505000197,044000114,858000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue207
Cost of Revenue-2,582
Gross Profit-2,375-2,375
 
Operating Income (+$)
Gross Profit-2,375
Operating Expense-20,724
Operating Income-20,517-23,099
 
Operating Expense (+$)
Research Development21,234
Selling General Administrative20,057
Selling And Marketing Expenses1,014
Operating Expense20,72442,305
 
Net Interest Income (+$)
Interest Income1,125
Interest Expense-71
Other Finance Cost-339
Net Interest Income715
 
Pretax Income (+$)
Operating Income-20,517
Net Interest Income715
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,512-21,522
EBIT - interestExpense = -20,588
-19,512
-15,639
Interest Expense71
Earnings Before Interest and Taxes (EBIT)-20,517-19,441
Earnings Before Interest and Taxes (EBITDA)-16,859
 
After tax Income (+$)
Income Before Tax-19,512
Tax Provision-4,286
Net Income From Continuing Ops-15,710-23,798
Net Income-15,710
Net Income Applicable To Common Shares21,904
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses20,724
Total Other Income/Expenses Net1,005-715
 

Technical Analysis of Moberg Pharma AB (publ)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Moberg Pharma AB (publ). The general trend of Moberg Pharma AB (publ) is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Moberg Pharma AB (publ)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Moberg Pharma AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 40.90.

The bearish price targets are: 17.90 > 15.20 > 14.60.

Tweet this
Moberg Pharma AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Moberg Pharma AB (publ). The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Moberg Pharma AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Moberg Pharma AB (publ). The current macd is 3.01767986.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Moberg Pharma AB (publ) price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Moberg Pharma AB (publ). This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Moberg Pharma AB (publ) price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Moberg Pharma AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartMoberg Pharma AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Moberg Pharma AB (publ). The current adx is 41.67.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Moberg Pharma AB (publ) shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Moberg Pharma AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Moberg Pharma AB (publ). The current sar is 39.26.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Moberg Pharma AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Moberg Pharma AB (publ). The current rsi is 49.46. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Moberg Pharma AB (publ) Daily Relative Strength Index (RSI) ChartMoberg Pharma AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Moberg Pharma AB (publ). The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Moberg Pharma AB (publ) price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Moberg Pharma AB (publ) Daily Stochastic Oscillator ChartMoberg Pharma AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Moberg Pharma AB (publ). The current cci is -21.20940302.

Moberg Pharma AB (publ) Daily Commodity Channel Index (CCI) ChartMoberg Pharma AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Moberg Pharma AB (publ). The current cmo is -15.08002521.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Moberg Pharma AB (publ) Daily Chande Momentum Oscillator (CMO) ChartMoberg Pharma AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Moberg Pharma AB (publ). The current willr is -69.04522613.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Moberg Pharma AB (publ) is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Moberg Pharma AB (publ) Daily Williams %R ChartMoberg Pharma AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Moberg Pharma AB (publ).

Moberg Pharma AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Moberg Pharma AB (publ). The current atr is 3.44870769.

Moberg Pharma AB (publ) Daily Average True Range (ATR) ChartMoberg Pharma AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Moberg Pharma AB (publ). The current obv is 15,010,789.

Moberg Pharma AB (publ) Daily On-Balance Volume (OBV) ChartMoberg Pharma AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Moberg Pharma AB (publ). The current mfi is 60.77.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Moberg Pharma AB (publ) Daily Money Flow Index (MFI) ChartMoberg Pharma AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Moberg Pharma AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Moberg Pharma AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Moberg Pharma AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.462
Ma 20Greater thanMa 5029.353
Ma 50Greater thanMa 10021.659
Ma 100Greater thanMa 20018.234
OpenGreater thanClose28.660
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Moberg Pharma AB (publ) with someone you think should read this too:
  • Are you bullish or bearish on Moberg Pharma AB (publ)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Moberg Pharma AB (publ)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Moberg Pharma AB (publ)

I send you an email if I find something interesting about Moberg Pharma AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about Moberg Pharma AB (publ).

Receive notifications about Moberg Pharma AB (publ) in your mailbox!